Dr. Amina Odidi is a founder and one of the principals of IntelliPharmaCeutics and serves as Director, President, Chief Operating Officer and Co-Chief Scientific Officer.
Since 1984 Dr. Amina Odidi has been a key player in the pharmaceutical industry by developing and applying proprietary technologies to the development of controlled-release drug products for third-party pharmaceutical companies.
Dr. Odidi received her B.Sc. degree in Pharmacy, from Ahmadu Bello University, and her M.Sc., Biopharmaceutics and Ph.D Pharmaceutics degrees from the University of London, England.
Dr. Odidi is an acclaimed scientist and innovator in the research, design, development and fabrication of controlled delivery technology platforms for sustained, timed, delayed, pulsatile or targeted delivery of pharmaceutical, nutraceutical, biological, chemical and agricultural materials in mammalian, terrestrial and extra-terrestrial environments. Dr. Odidi invented or co-invented various proprietary controlled delivery devices for the delivery of pharmaceutical, nutraceutical, biological, agricultural and chemical agents. She has held several senior management positions in the pharmaceutical and healthcare industries.
Dr. Odidi's role in the company is to oversee and assist in the development of key proprietary technology, from conception, through research and development, scale-up and manufacture, to clinical trials and regulatory approval. Dr. Amina Odidi will also provide strategic direction, managerial and scientific guidance. Professor Isa Odidi, together with Dr. Amina Odidi developed, between 1984 and 1995, the majority of the proprietary drug delivery technology used by IntelliPharmaCeutics for the production of controlled-release drug products. Dr. Amina Odidi continued this development from 1995 to date.
